Skip to main content
logo
Checkpoint Therapeutics, Inc. (CKPT)
4.260
0.00 (0.00%)
Inactive · Last trade price on May 29, 2025

Checkpoint Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
3571565452261180
Market Cap Growth
-190.05%2.84%-79.89%44.83%102.61%
Enterprise Value
3241525232200138
Last Close Price
4.263.202.295.1131.1026.50

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
8703.263811.32523.05272.85972.14168.28
PB Ratio
21.90-12.38-4.13-2.698.765.09
P/TBV Ratio
21.90---8.765.09

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EV/Sales Ratio
7897.353696.61505.85166.19747.51128.96

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Asset Turnover
0.000.010.010.010.010.03
Quick Ratio
1.850.330.270.372.115.65
Current Ratio
1.910.370.290.412.155.90
Return on Equity (ROE)
-1869.55%---1220.38%-174.03%-85.13%
Return on Assets (ROA)
-152.73%-546.48%-349.18%-105.65%-72.11%-41.69%
Return on Invested Capital (ROIC)
-1165.74%---710.48%-108.87%-53.48%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-15.84%-35.99%-96.24%-119.54%-21.75%-12.83%
Buyback Yield / Dilution
-30.01%-43.01%-169.69%-21.63%-51.48%-58.14%
SEC Filings: 10-K · 10-Q